Skip to main content
logo
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,768.00
-124.00 (-6.55%)
Oct 12, 2026, 3:30 PM KST

NeoImmuneTech Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
174,798405,851556,1291,001,0331,974,0795,091,787
Market Cap Growth
-52.47%-27.02%-44.44%-49.29%-61.23%-
Enterprise Value
138,804345,927519,849923,7121,838,8434,930,203
Last Close Price
1768.004105.004672.018409.6216590.8442982.51

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
99.324280.053263.98---
PB Ratio
3.106.8513.3513.3716.4931.42
P/TBV Ratio
4.838.7515.8014.5717.4532.76

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
78.873648.103051.04---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.200.180.260.050.040.04
Net Debt / Equity Ratio
-0.64-0.85-0.57-0.87-0.94-0.92
Net Debt / EBITDA Ratio
1.972.200.641.242.032.97
Net Debt / FCF Ratio
1.522.000.591.292.504.06
Asset Turnover
0.030.000.00---
Quick Ratio
2.682.941.675.367.147.57
Current Ratio
2.833.081.895.617.208.17
Return on Equity (ROE)
-61.03%-63.04%-70.17%-54.90%-42.88%-42.62%
Return on Assets (ROA)
-21.14%-21.48%-32.84%-30.30%-22.25%-22.95%
Return on Capital Employed (ROCE)
-36.40%-41.30%-91.80%-71.90%-47.10%-31.20%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-13.99%-7.83%-7.35%-5.33%-3.06%-1.03%
FCF Yield
-13.57%-6.19%-7.30%-5.05%-2.27%-0.72%
Buyback Yield / Dilution
-110.94%-19.34%0.24%-0.08%-3.68%-15.27%